Document is current
Any future updates will be listed below
-
Authors
Arnaldi, Dario https://orcid.org/0000-0001-6823-6069
Mattioli, Pietro
Orso, Beatrice
Raffa, Stefano
Lanfranchi, Francesco
Massa, Federico
Iranzo, Alex
Perissinotti, Andres
Niñerola-Baizán, Aida
Gaig, Carles
Serradell, Monica
Montini, Angelica
Mayà, Gerard
Muñoz-Lopetegi, Amaia
Liguori, Claudio
Fernandes, Mariana
Placidi, Fabio
Chiaravalloti, Agostino
Šonka, Karel
Dušek, Petr
Zogala, David
Trnka, Jiri
Boeve, Bradley F.
Miyagawa, Toji
Lowe, Val J.
Miyamoto, Tomoyuki
Miyamoto, Masayuki
Puligheddu, Monica
Figorilli, Michela
Serra, Alessandra
Hu, Michele T.
Klein, Johannes C.
Bes, Frederik
Kunz, Dieter
Cochen De Cock, Valérie
De Verbizier, Delphine
Plazzi, Giuseppe
Antelmi, Elena
Pizza, Fabio
Terzaghi, Michele
Bossert, Irene
Kulcsárová, Kristína
Garibotto, Valentina
Nicastro, Nicolas
Lathuilière, Aurelien
Bonanni, Laura
Morbelli, Silvia
Roascio, Monica
Arnulfo, Gabriele
Pardini, Matteo
-
Funding
Funding for this research was provided by:
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 31 October 2025
Accepted: 2 March 2026
First Online: 1 April 2026
Declarations
:
: Bradley Boeve has received institutional research grant support for clinical trials from Alector, Transposon, Cognition Therapeutics, and EIP Pharma/Cervomed, and receives honoraria for Scientific Advisory Board activities for the Tau Consortium, funded by the Rainwater Charitable Foundation. Giuseppe Plazzi has received honoraria for Scientific Advisory Board activities from Alkermes, Bioprojet, Centessa, Idorsia, and Takeda. Val J. Lowe serves as a consultant for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, Eli Lilly and Company, PeerView Institute for Medical Education, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals, and the NIH (NIA, NCI). Michele T. Hu serves as a consultant for Helicon, NeuHealth Digital, Roche and Manus Neurodynamica. Previous consultancies are: Lundbeck, ESCAPE Bio, Evidera, Biogen MA, CuraSen Therapeutics, Roche Products Ltd, Jazz Pharma, Aventis Pharma. She is an advisory founder and shareholder of NeuHealth Digital Ltd (company number: 14492037), a digital biomarker platform to remotely manage condition progression for Parkinson’s. Beatrice Orso received a research grant from GE Healthcare. Fabio Pizza participated to Advisory Board (Takeda), received support for congress attendance (Bioprojet), received fees for symposia (Bioprojet). Laura Bonanni received research grants by the Italian Ministry of Health and by the Italian Ministry of Education. She serves as consultant for Eli Lilly Andrés Perissinotti has received honoraria from GE Healthcare as speaker in symposiums.
